Skip to main content

Yin yang 1 modulates taxane response in epithelial ovarian cancer.

Publication ,  Journal Article
Matsumura, N; Huang, Z; Baba, T; Lee, PS; Barnett, JC; Mori, S; Chang, JT; Kuo, W-L; Gusberg, AH; Whitaker, RS; Gray, JW; Fujii, S ...
Published in: Mol Cancer Res
February 2009

Survival of ovarian cancer patients is largely dictated by their response to chemotherapy, which depends on underlying molecular features of the malignancy. We previously identified YIN YANG 1 (YY1) as a gene whose expression is positively correlated with ovarian cancer survival. Herein, we investigated the mechanistic basis of this association. Epigenetic and genetic characteristics of YY1 in serous epithelial ovarian cancer were analyzed along with YY1 mRNA and protein. Patterns of gene expression in primary serous epithelial ovarian cancer and in the NCI60 database were investigated using computational methods. YY1 function and modulation of chemotherapeutic response in vitro was studied using small interfering RNA knockdown. Microarray analysis showed strong positive correlation between expression of YY1 and genes with YY1 and transcription factor E2F binding motifs in ovarian cancer and in the NCI60 cancer cell lines. Clustering of microarray data for these genes revealed that high YY1/E2F3 activity positively correlates with survival of patients treated with the microtubule-stabilizing drug paclitaxel. Increased sensitivity to taxanes, but not to DNA cross-linking platinum agents, was also characteristic of NCI60 cancer cell lines with a high YY1/E2F signature. YY1 knockdown in ovarian cancer cell lines results in inhibition of anchorage-independent growth, motility, and proliferation but also increases resistance to taxanes, with no effect on cisplatin sensitivity. These results, together with the prior demonstration of augmentation of microtubule-related genes by E2F3, suggest that enhanced taxane sensitivity in tumors with high YY1/E2F activity may be mediated by modulation of putative target genes with microtubule function.

Duke Scholars

Published In

Mol Cancer Res

DOI

ISSN

1541-7786

Publication Date

February 2009

Volume

7

Issue

2

Start / End Page

210 / 220

Location

United States

Related Subject Headings

  • YY1 Transcription Factor
  • Wound Healing
  • Taxoids
  • Survival Rate
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Small Interfering
  • RNA, Messenger
  • Promoter Regions, Genetic
  • Paclitaxel
  • Ovarian Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Matsumura, N., Huang, Z., Baba, T., Lee, P. S., Barnett, J. C., Mori, S., … Murphy, S. K. (2009). Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res, 7(2), 210–220. https://doi.org/10.1158/1541-7786.MCR-08-0255
Matsumura, Noriomi, Zhiqing Huang, Tsukasa Baba, Paula S. Lee, Jason C. Barnett, Seiichi Mori, Jeffrey T. Chang, et al. “Yin yang 1 modulates taxane response in epithelial ovarian cancer.Mol Cancer Res 7, no. 2 (February 2009): 210–20. https://doi.org/10.1158/1541-7786.MCR-08-0255.
Matsumura N, Huang Z, Baba T, Lee PS, Barnett JC, Mori S, et al. Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res. 2009 Feb;7(2):210–20.
Matsumura, Noriomi, et al. “Yin yang 1 modulates taxane response in epithelial ovarian cancer.Mol Cancer Res, vol. 7, no. 2, Feb. 2009, pp. 210–20. Pubmed, doi:10.1158/1541-7786.MCR-08-0255.
Matsumura N, Huang Z, Baba T, Lee PS, Barnett JC, Mori S, Chang JT, Kuo W-L, Gusberg AH, Whitaker RS, Gray JW, Fujii S, Berchuck A, Murphy SK. Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res. 2009 Feb;7(2):210–220.

Published In

Mol Cancer Res

DOI

ISSN

1541-7786

Publication Date

February 2009

Volume

7

Issue

2

Start / End Page

210 / 220

Location

United States

Related Subject Headings

  • YY1 Transcription Factor
  • Wound Healing
  • Taxoids
  • Survival Rate
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Small Interfering
  • RNA, Messenger
  • Promoter Regions, Genetic
  • Paclitaxel
  • Ovarian Neoplasms